Breast cancer arising in a BRCA-mutated background: therapeutic implications from an animal model and drug development

Annals of Oncology : Official Journal of the European Society for Medical Oncology
J Fasano, F Muggia

Abstract

To date, the presence of a hereditary background has not influenced the selection of drug treatment in breast cancer. However, increasingly, negative hormone receptors and Her2 (often referred to as 'triple negative') or a medullary carcinoma histology has been reported in BRCA mutation carriers. Accordingly, such patients are often considered for adjuvant protocols based on chemotherapy (and not based on endocrine manipulations or trastuzumab). Mouse models introducing a conditional BRCA-null expression in the breast have recently provided powerful support for cisplatin-based treatment and have implications for the design of adjuvant studies in these patients.

References

Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten O NielsenCharles M Perou
Oct 29, 2004·Nature Reviews. Cancer·Nicholas TurnerAlan Ashworth
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sunil R LakhaniUNKNOWN Breast Cancer Linkage Consortium
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roman RouzierLajos Pusztai
Dec 13, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Chad A LivasyCharles M Perou
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Socorro María Rodríguez-PinillaJosé Palacios
Mar 25, 2006·Journal of Clinical Pathology·S BanerjeeI E Smith
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Lisa A CareyRobert C Millikan
Oct 4, 2006·Oncogene·N C TurnerA N Tutt
Oct 24, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Emad A RakhaIan O Ellis
Nov 14, 2006·The Breast : Official Journal of the European Society of Mastology·Kalliopi P Siziopikou, Melody Cobleigh
Mar 3, 2007·The Lancet Oncology·Susan CleatorR Charles Coombes
Apr 18, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lisa A CareyCharles M Perou
Apr 21, 2007·The Journal of Clinical Investigation·Chee-Onn LeongLeif W Ellisen
Jul 13, 2007·Proceedings of the National Academy of Sciences of the United States of America·Xiaoling LiuJos Jonkers
Jul 26, 2007·BMC Cancer·Marc TischkowitzWilliam D Foulkes
Aug 1, 2007·BMC Genomics·Katherine A HoadleyCharles M Perou
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Oct 9, 2007·Breast Cancer Research and Treatment·David S P TanJorge S Reis-Filho
Nov 8, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ColleoniA Goldhirsch
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cornelia LiedtkeLajos Pusztai
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maggie C U CheangTorsten O Nielsen
Apr 17, 2008·Cancer Research·Elizabeth M SwisherToshiyasu Taniguchi
Apr 18, 2008·Cell Cycle·Piet BorstJos Jonkers
Jul 4, 2008·Nature·Mark Brouard

❮ Previous
Next ❯

Citations

Oct 14, 2010·Virchows Archiv : an International Journal of Pathology·Pawel DomagalaWenancjusz Domagala
Feb 17, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·María Martín UresteJoaquín Montalar Salcedo
Jul 12, 2013·Drugs·Valentina GuarneriPierfranco Conte
May 1, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Muggia
Aug 9, 2011·Hereditary Cancer in Clinical Practice·Evgeny N Imyanitov, Vladimir M Moiseyenko
Oct 2, 2013·Annals of Surgical Oncology·Maryann KwaFranco Muggia
Apr 8, 2014·Cancers·Yong Weon YiInsoo Bae
Feb 15, 2012·Expert Opinion on Investigational Drugs·Xiaojun LiuWilliam Plunkett
May 27, 2011·Seminars in Oncology·Melody A Cobleigh
Mar 29, 2014·Scientific Reports·Sahil AhmadGajendra P S Raghava
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce G Haffty, Thomas A Buchholz
Apr 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charlie GourleyMichelle Ferguson
Oct 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Franco M MuggiaStephen B Howell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Deann P AtchleyBanu K Arun
Histopathology
Jorge S Reis-Filho, A N J Tutt
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Linda Vona-DavisGerald Hobbs
© 2021 Meta ULC. All rights reserved